Table 3 Comparison of fever response and coronary artery lesions between treatments
From: Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
Fever Response | Persistent non-giant dilation | Giant Aneurysm | ||||
|---|---|---|---|---|---|---|
Comparison | Risk Ratio [95% CI] | P value | Risk Ratio [95% CI] | P value | Risk Ratio [95% CI] | P value |
IVIg vs IVMP | 1.0 [0.9–1.2] | 0.9 | 0.9 [0.3–2.6] | 0.9 | 0.1 [0.01–0.9] | 0.01* |
IFX vs IVMP | 1.2 [1.0–1.5] | 0.04* | 1.2 [0.3–5.9] | 0.8 | 0 | 0.6# |
IFX vs IVIg | 1.2 [1.1–1.4] | 0.03* | 1.3 [0.3–5.6] | 0.7 | 0 | 1# |